N-(5-BROMOIMIDAZO[1,2-A]PYRIDIN-2-YL)-2,2,2-TRIFLUOROACETAMIDE, 95.0%, 250mg

Amino(4-tert-butylphenyl)acetic acid, 95+%, 1g

(4-Hydroxy-3-methylphenyl)(phenyl)methanone, 97%, 1g

4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine, 95.0%, 5g

N-(3-(((2-((4-Hydroxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)methyl)phenyl)-N-methylmethanesulfonamide, 98%, 250mg

(R)-2-Amino-2-(bicyclo[1.1.1]pentan-1-yl)acetic acid hydrochloride, 98%, 100mg

5-METHYL-1H-INDOLE-4-CARBOXYLIC ACID, 95%, 100mg

Ethyl 4-(chlorosulfonyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate, 97%, 1g

Tappi di ricambio x-cap / x-fold, 10 pezzi

{[1-(methoxymethyl)cyclobutyl]methyl}amine hydrochloride, 95.0%, 10g

MEthyl (2s)-2-amino-3-(furan-2-yl)propanoate, 95%, 1g

DBCO-Maleimide, 250mg

Bis(1-phenylethyl)sulfane, 97%, 25g